Profile data is unavailable for this security.
About the company
Jacobio Pharmaceuticals Group Co Ltd is a China-based investment holding company mainly engaged in the research and development of new drugs at the clinical stage. The Company is primarily responsible for the independent discovery and development of innovative tumor therapies. The Company's main drug development projects include JAB-3068 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The Company mainly conducts business within the domestic market.
- Revenue in HKD (TTM)68.24m
- Net income in HKD-385.83m
- Incorporated2018
- Employees301.00
- LocationJacobio Pharmaceuticals Group Co LtdBuilding F2, No. 88Kechuang 6th Street, Beijing EconomicTechnological Development AreaBEIJING ChinaCHN
- Phone+86 1 056315466
- Fax+86 1 056315314
- Websitehttp://www.jacobiopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JW (Cayman) Therapeutics Co Ltd | 186.78m | -825.11m | 747.12m | 398.00 | -- | 0.4103 | -- | 4.00 | -2.00 | -2.00 | 0.4539 | 4.39 | 0.0704 | 1.68 | 65.54 | 469,308.80 | -31.11 | -39.77 | -35.21 | -44.00 | 50.74 | -- | -441.74 | -1,316.81 | 3.86 | -47.82 | 0.1592 | -- | 19.32 | -- | 9.23 | -- | -19.87 | -- |
| Brii Biosciences Ltd | 662.88k | -187.83m | 766.49m | 128.00 | -- | 0.2286 | -- | 1,156.30 | -0.2582 | -0.2582 | 0.0009 | 4.59 | 0.0002 | -- | -- | 5,178.78 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
| Sunho Biologics Inc | -100.00bn | -100.00bn | 968.20m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -155.25 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 68.24m | -385.83m | 1.34bn | 301.00 | -- | 1.17 | -- | 19.67 | -0.4991 | -0.4991 | 0.0883 | 1.46 | 0.0419 | -- | 5.21 | 226,723.30 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| Hua Medicine | 82.31m | -226.94m | 1.40bn | 177.00 | -- | 12.00 | -- | 17.06 | -0.2322 | -0.2322 | 0.0842 | 0.1108 | 0.0538 | 1.69 | 13.03 | 465,012.10 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
| Wuhan YZY Biopharma Co Ltd | 0.00 | -205.96m | 1.45bn | 123.00 | -- | 10.56 | -- | -- | -1.11 | -1.11 | 0.00 | 0.7075 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.41 | -100.12 | 0.4138 | -- | -- | -- | -1.50 | -- | -- | -- |
| Mabpharm Ltd | 93.64m | -224.92m | 1.48bn | 347.00 | -- | 6.74 | -- | 15.85 | -0.0546 | -0.0546 | 0.0227 | 0.0534 | 0.0893 | 0.1176 | 6.02 | 269,863.90 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| TOT Biopharm International Co Ltd | 838.68m | -40.56m | 1.51bn | 551.00 | -- | 2.04 | 287.90 | 1.80 | -0.0559 | -0.0559 | 1.16 | 0.9547 | 0.5808 | 1.87 | 8.03 | 1,522,107.00 | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
| CStone Pharmaceuticals | 498.34m | -394.54m | 1.58bn | 230.00 | -- | 3.22 | -- | 3.17 | -0.3128 | -0.3128 | 0.3945 | 0.3822 | 0.2811 | 2.44 | 3.72 | 2,166,678.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| Frontage Holdings Corp | 2.03bn | 84.41m | 1.59bn | 1.76k | 19.10 | 0.5931 | 4.39 | 0.7824 | 0.0409 | 0.0409 | 0.9806 | 1.32 | 0.463 | 60.63 | 5.32 | 1,153,777.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Immunotech Biopharm Ltd | 0.00 | -359.72m | 1.67bn | 211.00 | -- | 8.97 | -- | -- | -0.699 | -0.699 | 0.00 | 0.3625 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -2.51 | 0.4327 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
| Laekna Inc | 0.00 | -396.24m | 1.73bn | 89.00 | -- | 2.00 | -- | -- | -3.28 | -3.28 | 0.00 | 2.21 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.28 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
Data as of Jul 23 2024. Currency figures normalised to Jacobio Pharmaceuticals Group Co Ltd's reporting currency: Hong Kong Dollar HKD
10.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hillhouse Investment Management Ltd. (Hong Kong)as of 19 Jun 2024 | 47.44m | 5.99% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 13.79m | 1.74% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 11.89m | 1.50% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 6.74m | 0.85% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 3.31m | 0.42% |
| Oriental Alpha Fund Management Co. Ltd.as of 31 Dec 2023 | 848.70k | 0.11% |
| Dimensional Fund Advisors LPas of 03 Jul 2024 | 786.60k | 0.10% |
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 687.60k | 0.09% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 468.90k | 0.06% |
| HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 369.60k | 0.05% |
More ▼
Data from 31 Dec 2023 - 17 Jul 2024Source: FactSet Research Systems Inc.
